Ifinatamab deruxtecan by Daiichi Sankyo for Lymphoma: Likelihood of Approval

Ifinatamab deruxtecan is under clinical development by Daiichi Sankyo and currently in Phase II for Lymphoma.

Bariatric Surgeries Decline as GLP-1s Use Rises, Impacting Hospital Margins

What You Should Know: – A new report from Strata Decision Technology reveals a significant decline in the number of bariatric surgeries performed in U.S.

November 15, 2024

Some countries are moving to digital prescription drug information for patients. The U.S. shouldn’t follow suit

Getting a new prescription can be overwhelming: medication schedules, foods to eat or avoid, interactions between different drugs. Having all of these details in accessible,

January 22, 2024

Ablation Bests Drugs for Ventricular Tachycardia After Heart Attack

CHICAGO — For patients with ventricular tachycardia (VT) and ischemic cardiomyopathy, going right to catheter ablation improved outcomes compared with trying antiarrhythmic drugs first, the

November 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.